[1]
(a) Schachter, M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update. Fundam. Clin. Pharmacol., 2004, 19, 117-125.
(b) Florey, K. Analytical Profiles of Drug Substances; Academic Press: New York, 1973, Vol. 2, .
(c) Adler, S.; Huang, H.; Trochu, J.N.; Xu, X.; Gupta, S.; Hintze, T.H. Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure. Am. J. Physiol. Renal Physiol., 2001, 281(5), 802-809.
[2]
(a) Saunders, K.D.; Cates, J.A.; Abedin, M.Z.; Roslyn, J.J. Lovastatin and gallstone dissolution: A preliminary study. Surgery, 1993, 113(1), 28-35.
(b) Gazzerro, P.; Proto, M.C.; Gangemi, G.; Malfitano, A.M.; Ciaglia, E.; Pisanti, S.; Santoro, A.; Laezza, C.; Bifulco, M.; Michael, M.G. Pharmacological actions of statins: A critical appraisal in the management of cancer. Pharmacol. Rev., 2012, 64(1), 102-146.
(c) Tazuma, S.; Hatsushika, S.; Aihara, N.; Sagawa, H.; Yamashita, G.; Sasaki, M.; Sasaki, H.; Mizuno, S.; Tao, S.; Kajiyama, G. Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs. Digestion, 1992, 51(3), 179-184.
[3]
(a) Grundy, S.M. Drugs for lipids. Treat. Guidel. Med. Lett., 2011, 9(103), 13-20.
(b) Weinreich, M.; Frishman, W.H. Antihyperlipidemic therapies targeting PCSK9. Cardiol. Rev., 2014, 22(3), 140-146.
[5]
Endo, A. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Antibiot. (Tokyo), 1980, 33(3), 334-336.
[6]
Hendrickson, L.; Davis, C.R.; Roach, C.; Nguyen, D.K.; Aldrich, T.; McAda, P.C.; Reeves, C.D. Lovastatin biosynthesis in Aspergillus terreus: Characterization of blocked mutants, enzyme activities and a multifunctional polyketide synthase gene. Chem. Biol., 1999, 6(7), 429-439.
[7]
Kennedy, J.; Auclair, K.; Kendrew, S.G.; Park, C.; Vederas, J.C.; Hutchinson, C.R. Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis. Science, 1999, 284(5418), 1368-1372.
[8]
(a) Tobert, J.A. Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat. Rev. Drug Discov., 2003, 2(7), 517-526.
(b) Todd, P.A.; Goa, K.L. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs, 1990, 40(4), 583-607.
[9]
Sánchez-Quesada, J.L.; Otal-Entraigas, C.; Franco, M.; Jorba, O.; González-Sastre, F.; Blanco-Vaca, F.; Ordóñez-Llanos, J. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia. Am. J. Cardiol., 1999, 84(6), 655-659.
[10]
McKenney, J.; Ballantyne, C.M.; Feldman, T.A.; Brady, W.E.; Shah, A.; Davies, M.J.; Palmisano, J.; Mitchel, Y.B. LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD. MedGenMed, 2005, 7(3), 3.
[11]
Endo, A.; Kuroda, M.; Tsujita, Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J. Antibiot. (Tokyo), 1976, 29(12), 1346-1348.
[12]
(a) Kumar Basniwal, P.; Jain, D. Simvastatin: review of updates on recent trends in pharmacokinetics, pharmacodynamics, drug–drug interaction, impurities and analytical methods. Curr. Pharm. Anal., 2012, 8(2), 135-156.
(b) Nikolic, T.; Zivkovic, V.; Srejovic, I.; Stojic, I.; Jeremic, N.; Jeremic, J.; Radonjic, K.; Stankovic, S.; Obrenovic, R.; Djuric, D.; Jakovljevic, V. Effects of atorvastatin and simvastatin on oxidative stress in diet-induced hyperhomocysteinemia in Wistar albino rats: A comparative study. Mol. Cell. Biochem., 2018, 437(1-2), 109-118.
[13]
(a) Gotto, A.M., Jr Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin. Am. J. Cardiol., 2005, 96(5A), 34F-38F.
(b) Mauro, V.F.; MacDonald, J.L. Simvastatin: a review of its pharmacology and clinical use. DICP, 1991, 25(3), 257-264.
[14]
Ward, S.; Lloyd Jones, M.; Pandor, A.; Holmes, M.; Ara, R.; Ryan, A.; Yeo, W.; Payne, N. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol. Assess., 2007, 11(14), 1-160. [iii-iv.].
[15]
(a) Pedersen, T.R.; Tobert, J.A. Simvastatin: A review. Expert Opin. Pharmacother., 2004, 5(12), 2583-2596.
(b) Wagner, J. A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents: implications for dosing guidelines. Clin. Pharmacol. Ther., 2019, 75, 1227-1235.
(c) Golomb, B.A.; Evans, M.A. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am. J. Cardiovasc. Drugs, 2008, 8(6), 373-418.
[16]
Kysilka, R.; Křen, V. Determination of Lovastatin (mevinolin) and mevinolinic acid in fermentation liquids. J. Chromatogr. A, 1993, 630(1-2), 415-417.
[17]
Hoffman, W.F.; Alberts, A.W.; Anderson, P.S.; Chen, J.S.; Smith, R.L.; Willard, A.K. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin. J. Med. Chem., 1986, 29(5), 849-852.
[18]
Hong, C.I.; Kim, J.W.; Shin, H.J.; Kang, T.W.; Cho, D.O. Process for
preparing simvastatin. US Patent 6,833,461., 2004.
[19]
Sleteinger, M.; Verhoeven, T.R.; Volante, R.P. Process for C-methylation of
2-methylbutyrates. US Patent 4,582,915., 1986.
[20]
Chatterjee, S.; Rawat, A.S.; Kumar, N.; Rajanikanth, J.; Shekhawat, K.S.; Shah, J.H.; Venkateswarlu, P. Process for preparing substantially pure
simvastatin. U.S. Patent Application No. 12/832,263., 2011.
[21]
Treiber, L.R. Process for the lactonization of mevinic acids and analogs
thereof. US Patent 4,916,239., 1990.
[22]
Hoffman, W.F.; Alberts, A.W.; Anderson, P.S.; Chen, J.S.; Smith, R.L.; Willard, A.K. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin. J. Med. Chem., 1986, 29(5), 849-852.
[23]
Verhoeven, T.R.; Askin, D. Process for α-C-alkylation of the 8-acyl group on
mevinolin and analogs thereof. US Patent 4,820,850., 1989.
[24]
Askin, D.; Verhoeven, T.; Liu, T.; Shinkai, I. Synthesis of synvinolin: Extremely high conversion alkylation of an ester enolate. J. Org. Chem., 1991, 56(16), 4929-4932.
[25]
Dabora, R. L.; Tewalt, G. L. Process to simvastatin ester. US5,159,104.,
1992.
[26]
Kubela, R.; Radhakrishnan, J. Process for producing simvastatin and analogs
thereof. US Patent US5,393,893., 1995.
[27]
Thaper, R.K.; Kumar, Y.; Dileep Kumar, S.; Misra, S.; Khanna, J.M. A cost-efficient synthesis of simvastatin via high-conversion methylation of an alkoxide ester enolate. Org. Process Res. Dev., 1999, 3(6), 476-479.
[28]
Murthy, K.K.; Horne, S.E.; Weeratunga, G.; Young, S. Process for producing
simvastatin. US Patent US6307066 B1., 2001.
[29]
Taoka, N.; Inoue, K. Process for producing simvastatin. U.S. Patent
6,331,641., 2001.
[30]
Karimian, K.; Tam, T.F.; Tao, Y.; Li, Y.; Doucette, G. Process to
manufacture simvastatin and intermediates. US Patent US 6,506,929 B1.,
2003.
[31]
Dabak, K.; Adiyaman, M. A new method for the synthesis of antihypercholesterolemic agent simvastatin. Helv. Chim. Acta, 2003, 86(3), 673-677.
[32]
Lee, K-H.; Kim, J-W.; Choi, K-D.; Bae, H. Process for producing
simvastatin. Us Patent US 6,576,775 B1., 2003.
[33]
Sambasivam, G.; Sridharan, M.; Acharya, P.; Mathew, J. Process for
manufacturing Simvastatin and novel intermediates thereof. US Patent
US6603022B1., 2003.
[34]
Dabak, K.; Keskin, H. A convenient procedure for the methylation of lovastatin: synthesis of simvastatin. Heterocycl. Commun., 2004, 10(1), 29-34.
[35]
Khanna, J.M.; Kumar, Y.; Thaper, R.K.; Misra, S.; Kumar, S.D. Key
intermediates in the manufacture of simvastatin. US Patent US5763653A.,
1998.
[36]
Dandala, R.; Sebastian, S.; Reddy, S.J.M.; Sivakumaran, M. Process for
lactonization to produce simvastatin. US Patent US6797831B2., 2004.
[37]
Korodi, F. Process for preparing simvastatin and intermediates thereof. U.S.
Patent 2007/0129437 A1., 2007.
[38]
(a) Gudipati, S.; Mandava, V.N.B.; Setty, R.K.S.; Manne, N.; Sagyam, R.; Vujjini, S.K. Process for preparing simvastatin. U.S. Patent
US20070117996A1. 2007.
(b) Singamsetty, R.K.; Vujjini, S.K.; Manne, N.; Venkata Naga, B.R.M.; Himabindu, V.; Battacharya, A.; Ghanta, M.R.; Bandichhor, R. New synthesis of simvastatin. Synth. Commun., 2008, 38(24), 4452-4459.
[39]
Shenqing, F.Z. Preparation of Simvastatin in ionic liquid. Chinese Patent
CNXXEV; CN104744416., 2015.
[40]
Xie, X.; Watanabe, K.; Wojcicki, W.A.; Wang, C.C.; Tang, Y. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase. Chem. Biol., 2006, 13(11), 1161-1169.
[41]
(a) Gao, X.; Wang, P.; Tang, Y. Engineered polyketide biosynthesis and biocatalysis in Escherichia coli. Appl. Microbiol. Biotechnol., 2010, 88(6), 1233-1242.
(b) Xie, X.; Tang, Y. Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl. Environ. Microbiol., 2007, 73(7), 2054-2060.
[42]
Huang, X.; Liang, Y.; Yang, Y.; Lu, X. Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus. Metab. Eng., 2017, 42, 109-114.
[43]
Sanishvili, R.; Yakunin, A.F.; Laskowski, R.A.; Skarina, T.; Evdokimova, E.; Doherty-Kirby, A.; Lajoie, G.A.; Thornton, J.M.; Arrowsmith, C.H.; Savchenko, A.; Joachimiak, A.; Edwards, A.M. Integrating structure, bioinformatics, and enzymology to discover function: BioH, a new carboxylesterase from Escherichia coli. J. Biol. Chem., 2003, 278(28), 26039-26045.
[44]
Kurek, W.; Koszelewski, D.; Ostaszewski, R.; Żądło-Dobrowolska, A. Bioreactor for the continuous purification of simvastatin by lovastatin esterase. Process Biochem., 2017, 60, 92-97.
[45]
Bond, C.M.; Tang, Y. Engineering Saccharomyces cerevisiae for production of simvastatin. Metab. Eng., 2019, 51, 1-8.
[46]
Barrios-González, J.; Miranda, R.U. Biotechnological production and applications of statins. Appl. Microbiol. Biotechnol., 2010, 85(4), 869-883.
[47]
Itoh, H.; Matsui, M.; Miyamura, Y.; Takeda, I.; Ishii, J.; Kumagai, T.; Machida, M.; Shibata, T.; Arita, M. Biosynthesis of novel statins by combining heterologous genes from Xylaria and Aspergillus. ACS Synth. Biol., 2018, 7(12), 2783-2789.
